Why companies left AIM in September

There were five departures from AIM during September. One company was taken over, another moved to the Main Market and the other three decided to leave for various reasons.   
7 September 2022
Stanley Gibbons Group
Stamp dealer Stanley Gibbons has had a tough time in recent years. The largest shareholder Phoenix SG believed it was better to cancel the quotation considering the limited free float and additional costs. The 58% shareholder also said that it would reconsider its financial support if shareholders did not agree to the cancelation. Stanley Gibbons is loss making.
The busine...

Aquis weekly movers: Arbuthnot Banking ahead of expectations

1

Arbuthnot Banking Group (LON: ARBB) says full results should be ahead of market expectations of a £13m pre-tax profit. The third quarter trading statement says Arbuthnot Latham deposits exceed £3bn, although costs of deposits are rising. Base rate rises have a positive effect on results as changes to deposit rates lag the rises in interest rates. Credit criteria are being tightened, particularly for property. Assets under management are £1.35bn. The share price improved by 17.9% to 825p. Non-exec Sir Nigel Boardman acquired 9.749 shares at 810p each. Arbuthnot Banking non-voting shares (LON: ARBN) slipped 1.8% to 545p.

Clean Invest Africa (LON: CIA) bounced back after last week’s share price slump after its results announcement and was the best performer on the Aquis Stock Exchange last week with a rise of 62.5% to 0.325p. KR1 (LON: KR1) is another company that has recovered some of last week’s post-results loss, rising 8.45% to 38.5p.

RentGuarantor Holdings (LON: RGG) rose again at the beginning of the week. There were four trades on Monday – at least three were buys – and the highest price was 200p. There were no more trades during the week and the share price is 12.1% higher at 185p.

Hydrogen Future Industries (LON: HFI) has acquired a suite of international patents through a joint venture. The patents are relevant for the company’s wind-based hydrogen production system, plus other systems. The patents were issued to the vendor when it employed the boss of HFI’s development subsidiary. The payment will be £33,000 in cash, 5.2 million shares and 2.5 warrants exercisable at 12p each, with the second tranche of the payment dependent on the achievement of development milestones. The share price rose 10.5% to 5.25p.

Coinsilium (LON: COIN) chairman Malcolm Palle acquired 500,000 shares at 1.9p each, while chief executive Eddy Travia bought 500,000 shares at 1.95p each. The share price rose 8.11% to 2p.

National Milk Records (LON: NMRP) generated a 6% increase in 2021-22 revenues to £23.2m, while pre-tax profit improved from £1.65m to £2.22m. The dividend was raised by one-third to 2p a share. The milk recording and testing services increased revenues. The biggest increase was in genomics which rose from £292,000 to £488,000 and there is a potential launch in the US during 2023. The share price was 4.74% higher at 110.5p.

There has been a mineral resource upgrade at the Amapa iron project in Brazil, and shares in 27% shareholder Cadence Minerals (LON: KDR) rose 3.72% to 9.75p, even though there was profit-taking after the announcement. The updated resource at Amapa is 276Mt grading 38.33% Fe, up from 177Mt. The measured resource is 55Mt grading 39.26% Fe.  

Hydro Hotel, Eastbourne (LON: HYDP) reinstated the interim dividend at the rate of 14p a share. The share price rose 20p to 970p.

Director buying at Kent-based brewer Shepherd Neame (LON: SHEP) pushed the share price 0.4% higher at 672.5p. Richard Oldfield bought 6,000 shares at 675p a share and George Barnes acquired 3,200 shares at 672p each. The final dividend is 15p a share and the shares go ex-dividend on 13 October.

==========

Fallers

Goodbody Health (LON: GDBY) secured a distribution agreement with blood collection services provider Tasso Inc, which supplies virtually painless medical devices to draw a blood sample with no needles. Goodbody’s clinics will be able to extract more blood than from a finger prick. The share price fell 18.2% to 9p.

Invinity Energy Systems (LON: IES) has sold a 1.3MWh VS3 flow battery system for use in a datacentre in Arizona. Amati reduced its stake from 5.87% to 4.92%. The share price fell 8.8% to 23.25p.

AIM weekly movers: Trellus Health reduces cash burn

1

The new management team at Trellus Health (LON: TRLS) is reducing the cash burn and there should be nought cash until the end of 2024. Trellus Health intends to provide personalised care for people with chronic conditions with the initial focus being inflammatory bowel disease (IBD). The service offered is what the company calls resilience-driven connected health, which is about digital care delivery and patient monitoring. The first monthly subscribers have been enrolled and contracts with businesses are under negotiation. There was $24m in the bank at the end of June 2022 and there could still be net cash of $17m at the end of the year. The shares rose 86.2% to 13.5p, having reached the all-time low on the previous Friday.

N4 Pharma (LON: N4P) successfully completed initial in vitro testing of its Nuvec delivery system loaded with two generic siRNA probes at the same time. Both probes were able to significantly silence their respective targets. These positive test results will help discussions with potential partners. Work continues on a treatment for lung cancer. The N4 Pharma share price rose 58.5% to 3.25p.

Oxford Biodynamics (LON: OBD) is raising £9.1m via a placing at 20p a share and up to a further £2.95m could be raised through a one-for-6.81644 open offer. The share price rose 56.3% to 17.975p, which is still well below the placing price. This cash will help to fund the commercial development of the EpiSwitch CiRT technology. The EpiSwitch CiRT checkpoint inhibitor response test for cancer has been issued with a US reimbursement code earlier in the week.

Infectious disease treatments developer Poolbeg Pharma (LON: POLB) received a positive response from the US Patents and Trademarks Office concerning its application for POLB001. Chief executive Jeremy Skillington subsequently bought an initial 718,733 shares at 4.78p each. Over the week the share price improved 46.6% to 6.45p.

Abingdon Health (LON: ABDX) shares bounced back after a judgement in relation to judicial review proceedings against the Department of Health and Social Care found that there was nothing wrong with the contracts awarded to the diagnostic tests company. The shares jumped 44% to 9p.

==========

Fallers

PCF Group (LON: PCF) was the worst performer last week after it suspended new lending by PCF Bank while it is trying to raise additional finance. Last week, Castle Trust Capital decided not to bid for PCF. Sales of assets and other options to raise money are being considered. There will be further cost cutting. The shares have fallen by 44.4% to 1.25p.

Two deals were not completed by student accommodation and build to rent developer Watkin Jones (LON: WJG) before the end of September and they have knocked at least 10% off 2021-22 profit to around £49m. The dividend could be trimmed to 7.8p a share, so that it is still twice covered by expected earnings. There are also cost pressures and interest rate rises will hamper future profitability. There was a one-third cut in 2022-23 pre-tax profit forecast to £50m as a precaution. Demand for student accommodation and build to rent property remains strong but margins will come under pressure. Net cash is £75m. The share price has slumped by 40.5% to 90p. Directors bought shares at between 101p and 102.25p each.

Tortilla Mexican Grill (LON: MEX) increased interim revenues by 30% to £26.9m, including like-for-like growth of 19%. The restaurants operator reported a slump in pre-tax profit from £2.63m to £264,000. That was mainly down to a reduction in government assistance from £1.88m to £211,000, plus costs relating to the Chilango acquisition. There has also been general cost inflation. The opening programme is ahead of target, but sales during the summer were disappointing. The share price has dived 29.1% to 103.5p.

There were three trades in Craven House Capital (LON: CRV) last week. It appears that Tuesday’s trade at 15 cents a share was behind the 28.9% drop in the share price to 16 cents a share.

Mobile content and data company Mobile Streams (LON: MOS) launched a placing and subscription raising £1.2m at 0.18p a share, which was a one-third discount to the market price. The shares have fallen 28.8% to 0.185p. A broker option enable existing shareholders to invest an additional £200,000 – there was demand for £400,000 worth of shares. The new shares come with warrants exercisable at 0.3p each. The cash will go towards NFT contracts. GTCR is no longer considering a bid for GB Group (LON: GBG) and the shares have fallen 23% to 469.2p.

Innovative Eyewear shares fly as corporate presentation released

Innovative Eyewear, a portfolio company of Tekcapital, saw its shares fly on Friday after the release of an updated corporate presentation.

The presentation had been updated to include details of the recent agreement with Nautica, a global lifestyle brand.

Innovative Eyewear shares were 93% higher at $3.15 at the time of writing on Friday.

Innovative Eyewear and their Lucyd smart eyewear technology is targeting a $28.3 billion total addressable eye wear market with blue-tooth enabled products.

Lucyd has 44 granted and pending patents, and having recently announced an agreement with Nautica, secured a formidable partner to accelerate distribution to end users.

Despite the challenging market conditions, Innovative Eyewear completed a successful listing on the NASDAQ raising $7.4m in August.

Tekcapital, the majority shareholder of Lucyd, saw their shares rise 8% in London as a result of the move in LUCY shares.

AIM movers: Oxford Biodynamics premium placing

0

Oxford Biodynamics (LON: OBD) is raising £9.1m via a placing at 20p a share and a further £2.95m could be raised through a one-for- 6.81644 open offer. The share price rose 22% to 18.3p. This cash will help to fund the commercial development of the EpiSwitch CiRT technology.

Abingdon Health (LON: ABDX) shares bounced back after the diagnostic tests company said a judgement in relation to judicial review proceedings against the Department of Health and Social Care is expected at 3pm. Abingdon Health is an interested party in the case. The shares have jumped 50% to 9.75p.

Richard Teatum has taken a 8.92% stake in retailer Joules Group (LON: JOUL). The share price rose 24.2% to 9.51p. He is a director of companies involved motor cars and parts retail, an advertising agency and Darrington Golf Club.

Director buying is helping the TPXimpact (LON: TPX) share price to recover a small proportion of its losses since the trading statement. Outgoing chief executive Neal Gandhi bought 49,000 shares at 40.5p and 171,000 shares at 35p each. Other directors have also been buying shares including Steve Winters who has acquired an initial 150,000 shares this week in two tranches at 36p a share and 41p a share. The shares have increase 17.3% to 47.5p.

ReNeuron (LON: RENE) says its newly named platform CustomEx has demonstrated an improved competitive profile beyond its tropism (natural affinity advantage) and other advantages. The new data shows improved exosome uptake in three tissue types and a higher level of siRNA delivery versus the rival HEK cell-generated exosomes. The share price is 5.77% higher at 27.5p, having been 28.5p earlier. They have fallen by two-thirds this year.

There has been a mineral resource upgrade at the Amapa iron project in Brazil, even so 27% shareholder Cadence Minerals (LON: KDR) is the worst performer on the day with a 13.5% decline. The updated resource at Amapa is 276Mt grading 38.33% Fe, up from 177Mt. The measured resource is 55Mt grading 39.26% Fe.  

Liontrust has disposed of its 10.1% stake in musicMagpie (LON: MMAG) during the past week. The share price fell a further 8.51% to 12.9p.

Tertiary Minerals (LON: TYM) has completed the sale of its royalty interests in the Kaaresselkä and Kiekerömaa properties in Finland to Aurion Resources Ltd. Tertiary Minerals has received C$200,000 in cash and 83,333 shares in Aurion. The Tertiary Minerals share price was 5.77% lower at 0.245p.

FTSE 100 outperforms US and European equities after Non-Farm Payrolls

September’s Non-Farm Payrolls provided a hawkish twist on Friday as investors accessed the health of the US jobs market and the impact on the trajectory of interest rate hikes.

The FTSE 100 had been tentatively higher before the jobs number a turned negative shortly after the release, but outperformed US and European stocks.

US jobs data revealed 263,000 increase in jobs in September versus economist estimates of 255,000 and a prior number of 315,000.

The Non Farm Payrolls will present the Fed with a major headache as they are forced to choose between supporting a slowing jobs market and combating soaring inflation.

Early indications are markets feel the jobs data will not be enough to cause a Fed ‘pivot’ away from interest hikes in the short-term. There are expectations the Fed will hike 75 bps at their next meeting.

Price action in the dollar drove the initial reaction as GBP/USD dipping to 1.1123. The stronger dollar in the run up to the data has taken cable down from 1.1500 just three trading sessions ago.

The jobs reading all but confirmed additional rate hikes and equity markets reacted by immediately selling equities. US futures extended declines with the NASDAQ down 1.2% and S&P 500 off 0.5%.

The weaker pound provide some support for the FTSE 100 as it outperformed US and European indices, slipping 0.3% to 6,970 at the time of wiring.

A close above 7,000 would have been a major psychological boost to investors in UK equities in the short-term.

The FTSE 100 has rebounded from the worst levels since the government’s mini-budget, but is still about 5% down from recent highs. Defensive names and a leading towards UK banks benefitting from higher rates has supported the index, as have overseas earners enjoying a weaker pound.

UK house prices fractionally decline according to Halifax

Average UK house prices fell 0.1% to £293,835 in September as the housing market showed further signs of cooling, albeit marginal.

“The average UK house price experienced a slight fall in September (-0.1%), the second marginal decrease over the past three months. The cost of a typical home edged down a little to £293,835 from the previous month’s record high (£293,992). The pace of annual growth also slowed for the third month in a row, to +9.9% from +11.4%, returning to single-digits for the first time since January,” said Kim Kinnaird, Director, Halifax Mortgages.

However small September’s decline was, recent economic developments point to further house price declines in the near term. The new Uk government’s shambolic fiscal package sent UK gilts soaring and ravaged the UK mortgage market. New fixed rate deals are currently around 6%, a huge jump for those coming to the end of their current terms.

The Bank of England is set to make another significant increase to the base rate at their next meeting.

“House prices fell slightly last month, reflecting the fact that demand was already falling earlier this summer – well before the mini-budget tipped the mortgage market into chaos. Once September’s rate hikes feed through into sales figures in the coming months, the risks of more significant house price falls will build,” said Sarah Coles, senior personal finance analyst, Hargreaves Lansdown

“It’s not a big month-on-month fall, but it’s the second in three months, and the quarter has seen the slowest growth in a year, so we’re definitely seeing a cooling in the market. September prices reflect decisions in June, when estate agents were reporting lower demand for the second consecutive month, and sales were slowing. In the RICS residential market report at the time, there were plenty of comments from agents who saw buyers start to drift away, and those who remained were more cautious.”

Wetherspoons investors raise a toast to improving revenues

Wetherspoons investors will be happy with a welcome increase in revenue in the 9 weeks to 2 October 2022 despite disappointing preliminary full year results.

Revenue in the 9 week period rose 10.1% compared to the same period a year prior. However, rising costs and supply chain issues saw the pub chain lose £30m over the full year.

Tim Martin, the Chairman of J D Wetherspoon plc, said: “previously reported increases in labour and repair costs and the potentially adverse effects of rises in interest rates and energy costs on the economy, firm predictions are hard to make.”

COVID Lockdowns

Wetherspoons investors have become accustomed to Mr Martin’s political punditry in market updates, and the Chairman did not disappoint in today’s release.

He took the opportunity to attribute the poor performance to the UK Government’s COVID policy and the release included references to studies that showed lockdowns did not prevent excess deaths.

Nonetheless, while earnings for the past year were impacted by lockdown, markets choose to look to recent positivity and JD  Wetherspoon shares were 12% higher at the time of writing.

“The results themselves yielded few surprises and it is encouraging to see a good uplift in sales so far in the first ten weeks of the current financial year. However, the question is how long this can go on for. Without doubt pubgoers have bigger hits to come to their wallet, be it from energy costs or increased mortgage payments,” said Derren Nathan, Head of Equity Research at Hargreaves Lansdown.

“JD Wetherspoon has its own cost challenges to face particularly when it comes to staff and maintaining the quality of its estate. With that in mind it is hard to see how further lockdowns are really the most tangible threat, and don’t anticipate a return to dividends any time soon given that net debt is hovering at close to £0.9m.”

Argo Blockchain shares dump in scramble to raise capital

Argo Blockchain shares sank on Friday as the Bitcoin miner released ‘strategic actions’ to strengthen the balance sheet as the company faced the challenges of higher power costs and low crypocurrency prices.

In a broad range of measures, Argo Blockchain appeared to be trying to raise capital in anyway they could, including selling off their mining machines, while continuing to host them at their Helios facility in Dickens County, Texas. Argo had previously announced a hosting agreement in August that gave Argo 25% of the net profits generated from the Bitcoin mined by the hosted mining machines.

Argo said they had also received a letter of intent from a strategic partners for a share subscription totalling £24m to help fund working capital and general corporate activities. The partner will have the right to appoint two non-exec directors to the board.

The subscription is limited to the partner meaning no other party will be involved in the capital raise.

Argo Blockchain shares sank 14% on the news to trade at 29p and lowest intraday levels since 2020.

“We have worked relentlessly to create and execute on a strategy that will support our objective of sustainable growth for the Company,” said Peter Wall, Chief Executive at Argo Blockchain.

“We also understand the importance of maintaining flexibility in our approach in order to respond swiftly to external factors. We are glad to have a strong relationship with our lender NYDIG, who has been working with us to provide flexibility and to help ensure the long term success of the Company.”

Argo Blockchain mined 235 Bitcoin or Bitcoin Equivalents in August and held 1,098 Bitcoin.

Eckoh – encouraging update news could engender enthusiasm for this group’s shares

Ahead of its Capital Markets Day next Tuesday, Eckoh (LON:ECK) the Hemel Hempstead-based provider of customer engagement security solutions, has updated its investors upon its first half sales.

To the end of September, the group enjoyed a strong upward momentum, driven mainly by renewed activity in its US markets.

Big improvement in sales

Order levels at over £17m are believed to be some 50% better than at this time last year.

The company is stating that it has made good progress in its strategy to pursue major opportunities for large blue-chip organisations, cross-sell from a broader product suite and continue the trend towards cloud adoption and more international mandates.  

International appeal for its services

Eckoh is increasingly focusing on attractive sectors which are suited to its model, technology, and product suite. Its Customer Engagement Security Solutions enable enquiries and transactions to be performed on whatever device the customer chooses, allowing organisations to increase efficiency, lower operational costs and provide a true omnichannel experience.

From its offices in both the UK and the US, it is a global provider to an international client base. It has a large portfolio of clients across a broad range of vertical markets and includes government departments, telecoms providers, retailers, utility providers and financial services organisations.

Analyst Opinion – shares are a Buy

Kevin Ashton and fellow analysts at Singer Capital Markets are enthusiastically encouraging investors to attend the Eckoh Capital Markets Day on Tuesday 11th October.

They are currently rating the group’s shares as a Buy having fixed a one-year Target Price of 92p on the group’s shares.

For the current year to end March 2023 they estimate sales of £40.0m (£31.8m), adjusted pre-tax profits of 7.6m (£5.2m) generating earnings of 2.0p (1.6p) and a dividend of 0.70p (0.61p) per share.

For next year they foresee £43.2m revenues, £8.3m profits, 2.0p earnings and a dividend of 0.80p per share.

Conclusion – a break above 50p very soon

This group’s brokers are very keen upon its shares.

They were as high as 64p in December last year, since when they have drifted back to a recent low of 37p a month ago.

Now at 44p these shares do have a growing following and, hopefully, the Capital Markets Day will impart enough information and enthusiasm as its brokers portray.

A break above 50p looks very achievable in the near-term.